Sangamo Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.17

+0.01 (+7.49%)

As of Aug 16, 10:42 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +12,197.0% upside

Low Target $11.90

Average Target $20.29

High Target $29.33

Current Price $0.17

Current
$0.17

Target
$20.29

$11.90 $20.29 avg $29.33

Scenario Analysis

Bear Case

$11.90

7,112.1%

Low target

Base Case

$20.29

+12,197.0%

Avg target

Bull Case

$29.33

+17,675.8%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$0.77

-78.5% from high

52-Week Low

$0.03

+450.0% from low

Target vs 52W High

$20.29

+2,548.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-0.5%
AMGN Amgen Inc	Hold	43	49%	$190.87	-55.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+152.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-17.0%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.5%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-54.1%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-47.2%
BIIB Biogen Inc	Buy	43	67%	$91.45	-57.0%